| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |